In this study, we examined RPN2 expression using immunohistochemical staining and quantitative real-time polymerase chain reaction (qRT-PCR) of pretreatment biopsy samples from patients with osteosarcoma, and evaluated the correlation between RPN2 expression and clinicopathological features. The gene discussed is RPN2; the disease is osteosarcoma.